Global Beta-Nicotinamide Mononucleotide (NMN) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Page: 104

Published Date: 22 Apr 2024

Category: Chemical & Material

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

Nicotinamide mononucleotide (NMN) is an intermediate of NAD+ biosynthesis produced from nicotinamide through nicotinamide phosphoribosyltransferase (NAMPT) and also referred to as NMN or nicotinamide ribotide. In recent studies of NMN applications to prevention and diagnosis of age-dependent diseases such as diabetes, neurodegenerative disorder, cardiac disease etc., it has become one of hottest biomarkers on discussion for anti-aging, lately.

According to our (Global Info Research) latest study, the global Beta-Nicotinamide Mononucleotide (NMN) market size was valued at US$ 371 million in 2023 and is forecast to a readjusted size of USD 774 million by 2030 with a CAGR of 10.6% during review period.

Core manufacturers of Nicotinamide Mononucleotide (NMN) include GeneHarbor, Mirarailab Bioscience, Maac10 Formulas, Herbalmax and Genex Formula. China is the largest production region, accounting for approximately 64% of the global market, followed by Japan and North America. In terms of product type, products with content ≥98% are the largest market segment, with a share of more than 99%. In terms of product application, the largest application market is health care products, with a share of approximately 99%.

This report is a detailed and comprehensive analysis for global Beta-Nicotinamide Mononucleotide (NMN) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:
Global Beta-Nicotinamide Mononucleotide (NMN) market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Kg), 2019-2030
Global Beta-Nicotinamide Mononucleotide (NMN) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Kg), 2019-2030
Global Beta-Nicotinamide Mononucleotide (NMN) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Kg), 2019-2030
Global Beta-Nicotinamide Mononucleotide (NMN) market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Kg), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Beta-Nicotinamide Mononucleotide (NMN)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Beta-Nicotinamide Mononucleotide (NMN) market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GeneHarbor, Herbalmax, Genex Formulas, Mirailab Bioscience, Maac10 Formulas, EffePharm, Bontac, CELFULL, Kingdomway, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation
Beta-Nicotinamide Mononucleotide (NMN) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Content ≥98%
    Content ＜98%

Market segment by Application
    Health Care Products
    Cosmetics
    Others

Major players covered
    GeneHarbor
    Herbalmax
    Genex Formulas
    Mirailab Bioscience
    Maac10 Formulas
    EffePharm
    Bontac
    CELFULL
    Kingdomway

Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Beta-Nicotinamide Mononucleotide (NMN) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Beta-Nicotinamide Mononucleotide (NMN), with price, sales quantity, revenue, and global market share of Beta-Nicotinamide Mononucleotide (NMN) from 2019 to 2024.
Chapter 3, the Beta-Nicotinamide Mononucleotide (NMN) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Beta-Nicotinamide Mononucleotide (NMN) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Beta-Nicotinamide Mononucleotide (NMN) market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Beta-Nicotinamide Mononucleotide (NMN).
Chapter 14 and 15, to describe Beta-Nicotinamide Mononucleotide (NMN) sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Content ≥98%
        1.3.3 Content ＜98%
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Health Care Products
        1.4.3 Cosmetics
        1.4.4 Others
    1.5 Global Beta-Nicotinamide Mononucleotide (NMN) Market Size & Forecast
        1.5.1 Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity (2019-2030)
        1.5.3 Global Beta-Nicotinamide Mononucleotide (NMN) Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 GeneHarbor
        2.1.1 GeneHarbor Details
        2.1.2 GeneHarbor Major Business
        2.1.3 GeneHarbor Beta-Nicotinamide Mononucleotide (NMN) Product and Services
        2.1.4 GeneHarbor Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 GeneHarbor Recent Developments/Updates
    2.2 Herbalmax
        2.2.1 Herbalmax Details
        2.2.2 Herbalmax Major Business
        2.2.3 Herbalmax Beta-Nicotinamide Mononucleotide (NMN) Product and Services
        2.2.4 Herbalmax Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Herbalmax Recent Developments/Updates
    2.3 Genex Formulas
        2.3.1 Genex Formulas Details
        2.3.2 Genex Formulas Major Business
        2.3.3 Genex Formulas Beta-Nicotinamide Mononucleotide (NMN) Product and Services
        2.3.4 Genex Formulas Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Genex Formulas Recent Developments/Updates
    2.4 Mirailab Bioscience
        2.4.1 Mirailab Bioscience Details
        2.4.2 Mirailab Bioscience Major Business
        2.4.3 Mirailab Bioscience Beta-Nicotinamide Mononucleotide (NMN) Product and Services
        2.4.4 Mirailab Bioscience Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Mirailab Bioscience Recent Developments/Updates
    2.5 Maac10 Formulas
        2.5.1 Maac10 Formulas Details
        2.5.2 Maac10 Formulas Major Business
        2.5.3 Maac10 Formulas Beta-Nicotinamide Mononucleotide (NMN) Product and Services
        2.5.4 Maac10 Formulas Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Maac10 Formulas Recent Developments/Updates
    2.6 EffePharm
        2.6.1 EffePharm Details
        2.6.2 EffePharm Major Business
        2.6.3 EffePharm Beta-Nicotinamide Mononucleotide (NMN) Product and Services
        2.6.4 EffePharm Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 EffePharm Recent Developments/Updates
    2.7 Bontac
        2.7.1 Bontac Details
        2.7.2 Bontac Major Business
        2.7.3 Bontac Beta-Nicotinamide Mononucleotide (NMN) Product and Services
        2.7.4 Bontac Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Bontac Recent Developments/Updates
    2.8 CELFULL
        2.8.1 CELFULL Details
        2.8.2 CELFULL Major Business
        2.8.3 CELFULL Beta-Nicotinamide Mononucleotide (NMN) Product and Services
        2.8.4 CELFULL Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 CELFULL Recent Developments/Updates
    2.9 Kingdomway
        2.9.1 Kingdomway Details
        2.9.2 Kingdomway Major Business
        2.9.3 Kingdomway Beta-Nicotinamide Mononucleotide (NMN) Product and Services
        2.9.4 Kingdomway Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Kingdomway Recent Developments/Updates

3 Competitive Environment: Beta-Nicotinamide Mononucleotide (NMN) by Manufacturer
    3.1 Global Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Manufacturer (2019-2024)
    3.2 Global Beta-Nicotinamide Mononucleotide (NMN) Revenue by Manufacturer (2019-2024)
    3.3 Global Beta-Nicotinamide Mononucleotide (NMN) Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of Beta-Nicotinamide Mononucleotide (NMN) by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 Beta-Nicotinamide Mononucleotide (NMN) Manufacturer Market Share in 2023
        3.4.3 Top 6 Beta-Nicotinamide Mononucleotide (NMN) Manufacturer Market Share in 2023
    3.5 Beta-Nicotinamide Mononucleotide (NMN) Market: Overall Company Footprint Analysis
        3.5.1 Beta-Nicotinamide Mononucleotide (NMN) Market: Region Footprint
        3.5.2 Beta-Nicotinamide Mononucleotide (NMN) Market: Company Product Type Footprint
        3.5.3 Beta-Nicotinamide Mononucleotide (NMN) Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Beta-Nicotinamide Mononucleotide (NMN) Market Size by Region
        4.1.1 Global Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Region (2019-2030)
        4.1.2 Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Region (2019-2030)
        4.1.3 Global Beta-Nicotinamide Mononucleotide (NMN) Average Price by Region (2019-2030)
    4.2 North America Beta-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030)
    4.3 Europe Beta-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030)
    4.4 Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030)
    4.5 South America Beta-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030)
    4.6 Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2019-2030)
    5.2 Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Type (2019-2030)
    5.3 Global Beta-Nicotinamide Mononucleotide (NMN) Average Price by Type (2019-2030)

6 Market Segment by Application
    6.1 Global Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2019-2030)
    6.2 Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Application (2019-2030)
    6.3 Global Beta-Nicotinamide Mononucleotide (NMN) Average Price by Application (2019-2030)

7 North America
    7.1 North America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2019-2030)
    7.2 North America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2019-2030)
    7.3 North America Beta-Nicotinamide Mononucleotide (NMN) Market Size by Country
        7.3.1 North America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2019-2030)
        7.3.2 North America Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2019-2030)
    8.2 Europe Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2019-2030)
    8.3 Europe Beta-Nicotinamide Mononucleotide (NMN) Market Size by Country
        8.3.1 Europe Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2019-2030)
        8.3.2 Europe Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Market Size by Region
        9.3.1 Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 South Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2019-2030)
    10.2 South America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2019-2030)
    10.3 South America Beta-Nicotinamide Mononucleotide (NMN) Market Size by Country
        10.3.1 South America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2019-2030)
        10.3.2 South America Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Market Size by Country
        11.3.1 Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 Beta-Nicotinamide Mononucleotide (NMN) Market Drivers
    12.2 Beta-Nicotinamide Mononucleotide (NMN) Market Restraints
    12.3 Beta-Nicotinamide Mononucleotide (NMN) Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Beta-Nicotinamide Mononucleotide (NMN) and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Beta-Nicotinamide Mononucleotide (NMN)
    13.3 Beta-Nicotinamide Mononucleotide (NMN) Production Process
    13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Beta-Nicotinamide Mononucleotide (NMN) Typical Distributors
    14.3 Beta-Nicotinamide Mononucleotide (NMN) Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
 Table 2. Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Table 3. GeneHarbor Basic Information, Manufacturing Base and Competitors
 Table 4. GeneHarbor Major Business
 Table 5. GeneHarbor Beta-Nicotinamide Mononucleotide (NMN) Product and Services
 Table 6. GeneHarbor Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 7. GeneHarbor Recent Developments/Updates
 Table 8. Herbalmax Basic Information, Manufacturing Base and Competitors
 Table 9. Herbalmax Major Business
 Table 10. Herbalmax Beta-Nicotinamide Mononucleotide (NMN) Product and Services
 Table 11. Herbalmax Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 12. Herbalmax Recent Developments/Updates
 Table 13. Genex Formulas Basic Information, Manufacturing Base and Competitors
 Table 14. Genex Formulas Major Business
 Table 15. Genex Formulas Beta-Nicotinamide Mononucleotide (NMN) Product and Services
 Table 16. Genex Formulas Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 17. Genex Formulas Recent Developments/Updates
 Table 18. Mirailab Bioscience Basic Information, Manufacturing Base and Competitors
 Table 19. Mirailab Bioscience Major Business
 Table 20. Mirailab Bioscience Beta-Nicotinamide Mononucleotide (NMN) Product and Services
 Table 21. Mirailab Bioscience Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 22. Mirailab Bioscience Recent Developments/Updates
 Table 23. Maac10 Formulas Basic Information, Manufacturing Base and Competitors
 Table 24. Maac10 Formulas Major Business
 Table 25. Maac10 Formulas Beta-Nicotinamide Mononucleotide (NMN) Product and Services
 Table 26. Maac10 Formulas Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 27. Maac10 Formulas Recent Developments/Updates
 Table 28. EffePharm Basic Information, Manufacturing Base and Competitors
 Table 29. EffePharm Major Business
 Table 30. EffePharm Beta-Nicotinamide Mononucleotide (NMN) Product and Services
 Table 31. EffePharm Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 32. EffePharm Recent Developments/Updates
 Table 33. Bontac Basic Information, Manufacturing Base and Competitors
 Table 34. Bontac Major Business
 Table 35. Bontac Beta-Nicotinamide Mononucleotide (NMN) Product and Services
 Table 36. Bontac Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 37. Bontac Recent Developments/Updates
 Table 38. CELFULL Basic Information, Manufacturing Base and Competitors
 Table 39. CELFULL Major Business
 Table 40. CELFULL Beta-Nicotinamide Mononucleotide (NMN) Product and Services
 Table 41. CELFULL Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 42. CELFULL Recent Developments/Updates
 Table 43. Kingdomway Basic Information, Manufacturing Base and Competitors
 Table 44. Kingdomway Major Business
 Table 45. Kingdomway Beta-Nicotinamide Mononucleotide (NMN) Product and Services
 Table 46. Kingdomway Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 47. Kingdomway Recent Developments/Updates
 Table 48. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Manufacturer (2019-2024) & (Tons)
 Table 49. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue by Manufacturer (2019-2024) & (USD Million)
 Table 50. Global Beta-Nicotinamide Mononucleotide (NMN) Average Price by Manufacturer (2019-2024) & (US$/Kg)
 Table 51. Market Position of Manufacturers in Beta-Nicotinamide Mononucleotide (NMN), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
 Table 52. Head Office and Beta-Nicotinamide Mononucleotide (NMN) Production Site of Key Manufacturer
 Table 53. Beta-Nicotinamide Mononucleotide (NMN) Market: Company Product Type Footprint
 Table 54. Beta-Nicotinamide Mononucleotide (NMN) Market: Company Product Application Footprint
 Table 55. Beta-Nicotinamide Mononucleotide (NMN) New Market Entrants and Barriers to Market Entry
 Table 56. Beta-Nicotinamide Mononucleotide (NMN) Mergers, Acquisition, Agreements, and Collaborations
 Table 57. Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Region (2019-2023-2030) & (USD Million) & CAGR
 Table 58. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Region (2019-2024) & (Tons)
 Table 59. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Region (2025-2030) & (Tons)
 Table 60. Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Region (2019-2024) & (USD Million)
 Table 61. Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Region (2025-2030) & (USD Million)
 Table 62. Global Beta-Nicotinamide Mononucleotide (NMN) Average Price by Region (2019-2024) & (US$/Kg)
 Table 63. Global Beta-Nicotinamide Mononucleotide (NMN) Average Price by Region (2025-2030) & (US$/Kg)
 Table 64. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2019-2024) & (Tons)
 Table 65. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2025-2030) & (Tons)
 Table 66. Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Type (2019-2024) & (USD Million)
 Table 67. Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Type (2025-2030) & (USD Million)
 Table 68. Global Beta-Nicotinamide Mononucleotide (NMN) Average Price by Type (2019-2024) & (US$/Kg)
 Table 69. Global Beta-Nicotinamide Mononucleotide (NMN) Average Price by Type (2025-2030) & (US$/Kg)
 Table 70. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2019-2024) & (Tons)
 Table 71. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2025-2030) & (Tons)
 Table 72. Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Application (2019-2024) & (USD Million)
 Table 73. Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Application (2025-2030) & (USD Million)
 Table 74. Global Beta-Nicotinamide Mononucleotide (NMN) Average Price by Application (2019-2024) & (US$/Kg)
 Table 75. Global Beta-Nicotinamide Mononucleotide (NMN) Average Price by Application (2025-2030) & (US$/Kg)
 Table 76. North America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2019-2024) & (Tons)
 Table 77. North America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2025-2030) & (Tons)
 Table 78. North America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2019-2024) & (Tons)
 Table 79. North America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2025-2030) & (Tons)
 Table 80. North America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2019-2024) & (Tons)
 Table 81. North America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2025-2030) & (Tons)
 Table 82. North America Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2019-2024) & (USD Million)
 Table 83. North America Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2025-2030) & (USD Million)
 Table 84. Europe Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2019-2024) & (Tons)
 Table 85. Europe Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2025-2030) & (Tons)
 Table 86. Europe Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2019-2024) & (Tons)
 Table 87. Europe Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2025-2030) & (Tons)
 Table 88. Europe Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2019-2024) & (Tons)
 Table 89. Europe Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2025-2030) & (Tons)
 Table 90. Europe Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2019-2024) & (USD Million)
 Table 91. Europe Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2025-2030) & (USD Million)
 Table 92. Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2019-2024) & (Tons)
 Table 93. Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2025-2030) & (Tons)
 Table 94. Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2019-2024) & (Tons)
 Table 95. Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2025-2030) & (Tons)
 Table 96. Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Region (2019-2024) & (Tons)
 Table 97. Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Region (2025-2030) & (Tons)
 Table 98. Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Region (2019-2024) & (USD Million)
 Table 99. Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Region (2025-2030) & (USD Million)
 Table 100. South America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2019-2024) & (Tons)
 Table 101. South America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2025-2030) & (Tons)
 Table 102. South America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2019-2024) & (Tons)
 Table 103. South America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2025-2030) & (Tons)
 Table 104. South America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2019-2024) & (Tons)
 Table 105. South America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2025-2030) & (Tons)
 Table 106. South America Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2019-2024) & (USD Million)
 Table 107. South America Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2025-2030) & (USD Million)
 Table 108. Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2019-2024) & (Tons)
 Table 109. Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2025-2030) & (Tons)
 Table 110. Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2019-2024) & (Tons)
 Table 111. Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2025-2030) & (Tons)
 Table 112. Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2019-2024) & (Tons)
 Table 113. Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2025-2030) & (Tons)
 Table 114. Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2019-2024) & (USD Million)
 Table 115. Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2025-2030) & (USD Million)
 Table 116. Beta-Nicotinamide Mononucleotide (NMN) Raw Material
 Table 117. Key Manufacturers of Beta-Nicotinamide Mononucleotide (NMN) Raw Materials
 Table 118. Beta-Nicotinamide Mononucleotide (NMN) Typical Distributors
 Table 119. Beta-Nicotinamide Mononucleotide (NMN) Typical Customers


List of Figures
 Figure 1. Beta-Nicotinamide Mononucleotide (NMN) Picture
 Figure 2. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue by Type, (USD Million), 2019 & 2023 & 2030
 Figure 3. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Type in 2023
 Figure 4. Content ≥98% Examples
 Figure 5. Content ＜98% Examples
 Figure 6. Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Figure 7. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application in 2023
 Figure 8. Health Care Products Examples
 Figure 9. Cosmetics Examples
 Figure 10. Others Examples
 Figure 11. Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Value, (USD Million): 2019 & 2023 & 2030
 Figure 12. Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Value and Forecast (2019-2030) & (USD Million)
 Figure 13. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity (2019-2030) & (Tons)
 Figure 14. Global Beta-Nicotinamide Mononucleotide (NMN) Price (2019-2030) & (US$/Kg)
 Figure 15. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Manufacturer in 2023
 Figure 16. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Manufacturer in 2023
 Figure 17. Producer Shipments of Beta-Nicotinamide Mononucleotide (NMN) by Manufacturer Sales ($MM) and Market Share (%): 2023
 Figure 18. Top 3 Beta-Nicotinamide Mononucleotide (NMN) Manufacturer (Revenue) Market Share in 2023
 Figure 19. Top 6 Beta-Nicotinamide Mononucleotide (NMN) Manufacturer (Revenue) Market Share in 2023
 Figure 20. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Region (2019-2030)
 Figure 21. Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Value Market Share by Region (2019-2030)
 Figure 22. North America Beta-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030) & (USD Million)
 Figure 23. Europe Beta-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030) & (USD Million)
 Figure 24. Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030) & (USD Million)
 Figure 25. South America Beta-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030) & (USD Million)
 Figure 26. Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030) & (USD Million)
 Figure 27. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Type (2019-2030)
 Figure 28. Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Value Market Share by Type (2019-2030)
 Figure 29. Global Beta-Nicotinamide Mononucleotide (NMN) Average Price by Type (2019-2030) & (US$/Kg)
 Figure 30. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Application (2019-2030)
 Figure 31. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application (2019-2030)
 Figure 32. Global Beta-Nicotinamide Mononucleotide (NMN) Average Price by Application (2019-2030) & (US$/Kg)
 Figure 33. North America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Type (2019-2030)
 Figure 34. North America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Application (2019-2030)
 Figure 35. North America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Country (2019-2030)
 Figure 36. North America Beta-Nicotinamide Mononucleotide (NMN) Consumption Value Market Share by Country (2019-2030)
 Figure 37. United States Beta-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030) & (USD Million)
 Figure 38. Canada Beta-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030) & (USD Million)
 Figure 39. Mexico Beta-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030) & (USD Million)
 Figure 40. Europe Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Type (2019-2030)
 Figure 41. Europe Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Application (2019-2030)
 Figure 42. Europe Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Country (2019-2030)
 Figure 43. Europe Beta-Nicotinamide Mononucleotide (NMN) Consumption Value Market Share by Country (2019-2030)
 Figure 44. Germany Beta-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030) & (USD Million)
 Figure 45. France Beta-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030) & (USD Million)
 Figure 46. United Kingdom Beta-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030) & (USD Million)
 Figure 47. Russia Beta-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030) & (USD Million)
 Figure 48. Italy Beta-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030) & (USD Million)
 Figure 49. Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Type (2019-2030)
 Figure 50. Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Application (2019-2030)
 Figure 51. Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Region (2019-2030)
 Figure 52. Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Consumption Value Market Share by Region (2019-2030)
 Figure 53. China Beta-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030) & (USD Million)
 Figure 54. Japan Beta-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030) & (USD Million)
 Figure 55. South Korea Beta-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030) & (USD Million)
 Figure 56. India Beta-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030) & (USD Million)
 Figure 57. Southeast Asia Beta-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030) & (USD Million)
 Figure 58. Australia Beta-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030) & (USD Million)
 Figure 59. South America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Type (2019-2030)
 Figure 60. South America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Application (2019-2030)
 Figure 61. South America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Country (2019-2030)
 Figure 62. South America Beta-Nicotinamide Mononucleotide (NMN) Consumption Value Market Share by Country (2019-2030)
 Figure 63. Brazil Beta-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030) & (USD Million)
 Figure 64. Argentina Beta-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030) & (USD Million)
 Figure 65. Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Type (2019-2030)
 Figure 66. Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Application (2019-2030)
 Figure 67. Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Country (2019-2030)
 Figure 68. Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Consumption Value Market Share by Country (2019-2030)
 Figure 69. Turkey Beta-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030) & (USD Million)
 Figure 70. Egypt Beta-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030) & (USD Million)
 Figure 71. Saudi Arabia Beta-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030) & (USD Million)
 Figure 72. South Africa Beta-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030) & (USD Million)
 Figure 73. Beta-Nicotinamide Mononucleotide (NMN) Market Drivers
 Figure 74. Beta-Nicotinamide Mononucleotide (NMN) Market Restraints
 Figure 75. Beta-Nicotinamide Mononucleotide (NMN) Market Trends
 Figure 76. Porters Five Forces Analysis
 Figure 77. Manufacturing Cost Structure Analysis of Beta-Nicotinamide Mononucleotide (NMN) in 2023
 Figure 78. Manufacturing Process Analysis of Beta-Nicotinamide Mononucleotide (NMN)
 Figure 79. Beta-Nicotinamide Mononucleotide (NMN) Industrial Chain
 Figure 80. Sales Channel: Direct to End-User vs Distributors
 Figure 81. Direct Channel Pros & Cons
 Figure 82. Indirect Channel Pros & Cons
 Figure 83. Methodology
 Figure 84. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

GeneHarbor
Herbalmax
Genex Formulas
Mirailab Bioscience
Maac10 Formulas
EffePharm
Bontac
CELFULL
Kingdomway

Related Reports

Global Beta-Nicotinamide Mononucleotide (NMN) Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Beta-Nicotinamide Mononucleotide (NMN) Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 29 Jun 2023

date Chemical & Material

According to our (Global Info Research) latest study, the global Beta-Nicotinamide Mononucleotide (NMN) market size was valued at USD 306.1 million in 2022 and is forecast to a readjusted size of USD 679.1 million by 2029 with a CAGR of 12.1% during review period.

Global Beta-Nicotinamide Mononucleotide (NMN) Supply, Demand and Key Producers, 2023-2029

Global Beta-Nicotinamide Mononucleotide (NMN) Supply, Demand and Key Producers, 2023-2029

date 29 Jun 2023

date Chemical & Material

The global Beta-Nicotinamide Mononucleotide (NMN) market size is expected to reach $ 679.1 million by 2029, rising at a market growth of 12.1% CAGR during the forecast period (2023-2029).

Global Beta-Nicotinamide Mononucleotide (NMN) Supply, Demand and Key Producers, 2024-2030

Global Beta-Nicotinamide Mononucleotide (NMN) Supply, Demand and Key Producers, 2024-2030

date 22 Apr 2024

date Chemical & Material

Nicotinamide mononucleotide (NMN) is an intermediate of NAD+ biosynthesis produced from nicotinamide through nicotinamide phosphoribosyltransferase (NAMPT) and also referred to as NMN or nicotinamide ribotide. In recent studies of NMN applications to prevention and diagnosis of age-dependent diseases such as diabetes, neurodegenerative disorder, cardiac disease etc., it has become one of hottest biomarkers on discussion for anti-aging, lately.

Product Tags

Beta-Nicotinamide Mononucleotide (NMN)

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>